| Gastric Cancer |
0 |
1 |
| Noncolorectal Gastrointestinal Cancer |
0 |
0.99 |
| Cancer |
0 |
0.77 |
| Biologic Therapy |
0 |
0.64 |
| Cancer Risk |
0 |
0.98 |
| Genomic Medicine |
0 |
0.97 |
| Antiretroviral Therapy for HIV Infection |
0 |
0.11 |
| HIV Infection |
0 |
0.11 |
| Proton Pump Inhibitor |
0 |
0.11 |
| Nucleoside Reverse Transcriptase Inhibitors |
0 |
0.08 |
| Helicobacter Pylori |
0 |
0.96 |
| Patient Safety |
0 |
0.06 |
| Adverse Effects |
0 |
0.04 |
| Antigens |
0 |
0.04 |
| Chemotherapy |
0 |
0.04 |
| Clinical Guidelines |
0 |
0.04 |
| Endoscopy |
0 |
0.04 |
| Genetics |
0 |
0.95 |
| Hospital |
0 |
0.04 |
| Intestinal Metaplasia |
0 |
0.04 |
| Stomach |
0 |
0.04 |
| Surgery |
0 |
0.04 |
| Washington |
0 |
0.04 |